Complementary and Alternative Care in Multiple Sclerosis
Part of paid clinical trials in Kenmore, Washington.
- Sponsor
- Bastyr University
- Study ID
- NCT01703429
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants will be compared to controls in order to describe medication, diet, and lifestyle patterns associated with a lack of MS disease progression and high quality of life.
Key Dates
- Start date
- Jun 30, 2012
- Status verified
- Feb 2020
- Primary completion
- Jun 30, 2030
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Individuals with MS
Primary Outcome Measure
"CAM Therapies" survey [ Time Frame: 5 years ]
Central Contacts
- Research Assistant
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bastyr University Clinical Research Center | Kenmore | Washington | 98028 | Laurie K Mischley, ND, PhD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Kenmore, WA
Related Studies
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting · TG Therapeutics, Inc. · Birmingham, Alabama
- Confirmatory Trial for Alleviating Fatigue in Multiple SclerosisRecruiting · Accelerated Cure Project for Multiple Sclerosis · Washington D.C., District of Columbia
- Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple SclerosisPHASE1 · Recruiting · University of Washington · Seattle, Washington